Drug Profile
MDT 637
Alternative Names: MDT-637; VP-14637Latest Information Update: 16 Jan 2019
Price :
$50
*
At a glance
- Originator ViroPharma
- Developer MicroDose Therapeutx
- Class Antivirals; Small molecules
- Mechanism of Action Viral fusion protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Respiratory syncytial virus infections
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 11 Mar 2014 ViroPharma is now called Shire ViroPharma
- 24 Jan 2014 ViroPharma has been acquired by Shire